{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:48:51Z","timestamp":1786121331252,"version":"build-2736575974"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    Serotype 19A has emerged as an important cause of pneumococcal disease following the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10). In this retrospective study of children hospitalized with culture-confirmed invasive pneumococcal disease at an Ecuadorian pediatric reference hospital, among 46 cases, 43 (93%) were serotype 19A, with most presenting as severe complicated pneumonia. The majority had received three PCV10 doses. Penicillin nonsusceptibility was identified in 88% of isolates. Serotype 19A infections were associated with longer hospitalization and higher medical costs, highlighting the substantial burden of complicated pneumonia due to a non-PCV10 serotype.\n                  <\/jats:p>","DOI":"10.1097\/inf.0000000000005365","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:00:29Z","timestamp":1786075229000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Economic Burden of Complicated Pneumonia and Invasive Disease due to Streptococcus pneumoniae Serotype 19A in an Ecuadorian Pediatric Reference Hospital"],"prefix":"10.1097","author":[{"given":"El\u00edas David","family":"Salgado-Villalba","sequence":"first","affiliation":[{"name":"Centro de Salud Playa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngeles","family":"Costta-Michuy","sequence":"additional","affiliation":[{"name":"Hospital of Ancon, Instituto Ecuatoriano de Seguridad Social, Santa Elena, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena Del Rosario","family":"Villalba-Valencia","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico Baca Ortiz, Ministry of Public Health, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Carrasco-Ronquillo","sequence":"additional","affiliation":[{"name":"Centro de Salud Playa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Alejandra","family":"Salas-Haas","sequence":"additional","affiliation":[{"name":"Hospital de Especialidades Quito N\u00b01 de la Polic\u00eda Nacional del Ecuador, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Carolina","family":"Cifuentes-Carcel\u00e9n","sequence":"additional","affiliation":[{"name":"Private Medical Practice, Guayaquil, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Margarita","family":"Bracero-Velasco","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico Baca Ortiz, Ministry of Public Health, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne del Pilar Aucapi\u00f1a","family":"Aucapi\u00f1a-Aucapi\u00f1a","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico Baca Ortiz, Ministry of Public Health, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Palomeque-Velastegui","sequence":"additional","affiliation":[{"name":"Hospital Pedi\u00e1trico Baca Ortiz, Ministry of Public Health, Quito, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-2732","authenticated-orcid":false,"given":"Jaime David","family":"Acosta-Espa\u00f1a","sequence":"additional","affiliation":[{"name":"Health Sciences Faculty, Universidad Internacional SEK, Quito, Ecuador"},{"name":"School of Medicine, Pontificia Universidad Cat\u00f3lica del Ecuador, Quito, Ecuador"},{"name":"Graduate Program in Internal Medicine, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto, Brazil"},{"name":"Centro de Investigaci\u00f3n para la Salud en Am\u00e9rica Latina, Pontificia Universidad Cat\u00f3lica del Ecuador, Quito, Ecuador."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"R1-20260807","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(24)00665-0","article-title":"Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.","volume":"25","author":"Bennett","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1016\/j.vaccine.2018.06.068","article-title":"Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010-2015: a systematic review and a time series analysis.","volume":"36","author":"Agudelo","year":"2018","journal-title":"Vaccine"},{"key":"R3-20260807","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R5-20260807","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/14760584.2023.2184090","article-title":"A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia.","volume":"22","author":"Ord\u00f3\u00f1ez","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"R6-20260807","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1080\/21645515.2019.1710411","article-title":"Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogot\u00e1, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10.","volume":"16","author":"Camacho Moreno","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"R7-20260807","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/14760584.2017.1362339","article-title":"Streptococcus pneumoniae serotype 19A: worldwide epidemiology.","volume":"16","author":"Isturiz","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1080\/21645515.2021.1972709","article-title":"Laboratory-based surveillance in Latin America: attributes and limitations in evaluation of pneumococcal vaccine impact.","volume":"17","author":"Nieto Guevara","year":"2021","journal-title":"Hum Vaccin Immunother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:00:30Z","timestamp":1786075230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":7,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005365","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}